Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Aβ expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: A pilot study. [electronic resource]
Producer: 20181010Description: 211-222 p. digitalISSN:- 1950-6007
- ADAM10 Protein -- metabolism
- Adult
- Aged
- Aged, 80 and over
- Alzheimer Disease -- drug therapy
- Amyloid Precursor Protein Secretases -- metabolism
- Amyloid beta-Peptides -- metabolism
- Amyloid beta-Protein Precursor -- metabolism
- Aspartic Acid Endopeptidases -- metabolism
- Blood Platelets -- drug effects
- Brain -- drug effects
- Cognitive Dysfunction -- drug therapy
- Erythropoietin -- therapeutic use
- Female
- Humans
- Male
- Middle Aged
- Neuroprotective Agents -- therapeutic use
- Pilot Projects
- Presenilin-1 -- metabolism
- Proteins -- metabolism
- Recombinant Proteins -- therapeutic use
- Renal Insufficiency, Chronic -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.